Perfusion-weighted imaging/diffusion-weighted imaging mismatch on MRI can now be used to select patients for recombinant tissue plasminogen activator beyond 3 hours: pro

MeSH terms

• Diffusion Magnetic Resonance Imaging*
• Fibrinolytic Agents / therapeutic use*
• Humans
• Magnetic Resonance Angiography*
• Patient Selection
• Recombinant Proteins / therapeutic use
• Stroke / diagnosis*
• Stroke / drug therapy*
• Thrombolytic Therapy
• Tissue Plasminogen Activator / genetics
• Tissue Plasminogen Activator / therapeutic use*
• Tomography, X-Ray Computed